BAP Consensus Guidelines

Document Title Download Published
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology
Topic: Anxiety Disorder
Co-Authors: David S Baldwin, Ian M Anderson, David J Nutt, Christer Allgulander, Borwin Bandelow, Johan A den Boer, David M Christmas, Simon Davies, Naomi Fineberg, Nicky Lidbetter, Andrea Malizia, Paul McCrone, Daniel Nabarro, Catherine O’Neill, Jan Scott, Nic van der Wee and Hans-Ulrich Wittchen

683 Kb
2014

Full Details

Benzodiazepines: Risks and benefits. A reconsideration
Topic: Benzodiazepines
Co-Authors: David S Baldwin, Katherine Aitchison, Alan Bateson, H Valerie Curran, Simon Davies, Brian Leonard, David J Nutt, David N Stephens and Sue Wilson

726 Kb
2013

Full Details

Evidence based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from the British Association for Psychopharmacology
Topic: Addiction
Co-Authors: AR Lingford-Hughes, S Welch, L Peters and DJ Nutt

1,134 Kb
2012

Full Details

British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Topic: Insomnia
Co-Authors: SJ Wilson, DJ Nutt, C Alford, SV Argyropoulos, DS Baldwin, AN Bateson, TC Britton, C Crowe, D-J Dijk, CA Espie, P Gringras, G Hajak, C Idzikowski, AD Krystal, JR Nash, H Selsick, AL Sharpley and AG Wade

752 Kb
2010

Full Details

Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
Topic: Schizophrenia
Co-Authors: Thomas R E Barnes and the Consensus Group

422 Kb
2010

Full Details